Search

Your search keyword '"Griesmacher, A."' showing total 230 results

Search Constraints

Start Over You searched for: Author "Griesmacher, A." Remove constraint Author: "Griesmacher, A." Database Unpaywall Remove constraint Database: Unpaywall
230 results on '"Griesmacher, A."'

Search Results

1. High-Sensitivity Cardiac Troponin T and Cardiovascular Risk After Ischemic Stroke or Transient Ischemic Attack

2. CRP/Neopterin Ratio and Neuropsychiatric Symptoms in Patients with Different Forms of Pneumonia: Results of a Pilot Study

4. Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies

6. Complexity of coronary artery disease and the release of cardiac biomarkers after CABG

8. Postoperative cardiac biomarker release is not associated with myocardial mass in CT scans

9. Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study

10. Association of High-Sensitivity Cardiac Troponin T With 30-Day and 5-Year Mortality After Cardiac Surgery

11. Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities

12. Screening for osteoporosis in people with MS: A new risk score

15. Design of external quality assessment schemes and definition of the roles of their providers in future epidemics

17. Three rounds of a national external quality assessment reveal a link between disharmonic anti-SARS-CoV-2 antibody quantifications and the infection stage

18. Sexual dysfunction in female and male people with multiple sclerosis: disability, depression and hormonal status matter

19. Converting to an international unit system improves harmonization of results for SARS-CoV-2 quantification: Results from multiple external quality assessments

21. One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies

22. Converting to an international unit system improves harmonization of results for SARS-CoV-2 quantification: results from multiple external quality assessments

24. Design of external quality assessment (EQA) schemes and definition of the roles of their providers in future epidemics

26. Long-term outcome of a pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack: study protocol

28. Perfusate Enzymes and Platelets Indicate Early Allograft Dysfunction After Transplantation of Normothermically Preserved Livers

29. Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation

31. Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis

32. Borderline and weakly positive antibody levels against the S-protein of SARS-CoV-2 exhibit limited agreement with virus neutralization titres

33. External quality assessment providers’ services appear to more impact the immunohaematology performance of laboratories than national regulatory and economic conditions

34. Diagnostic Yield of a Systematic Vascular Health Screening Approach in Adolescents at Schools

35. Association of adolescent lipoprotein subclass profile with carotid intima-media thickness and comparison to adults: Prospective population-based cohort studies

36. Inadequate design of mutation detection panels prevents interpretation of variants of concern: results of an external quality assessment for SARS-CoV-2 variant detection

37. A look at the precision, sensitivity and specificity of SARS-CoV-2 RT-PCR assays through a dedicated external quality assessment round

38. Predictors of Carotid Intima‐Media Thickness Progression in Adolescents—The EVA‐Tyrol Study

40. The versatility of external quality assessment for the surveillance of laboratory and in vitro diagnostic performance: SARS-CoV-2 viral genome detection in Austria

41. Testosterone Deficiency Is a Risk Factor for Severe COVID-19

42. Pharmacokinetics and Antifungal Activity of Echinocandins in Ascites Fluid of Critically Ill Patients

43. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients

45. A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests

46. Penetration of echinocandins into wound secretion of critically ill patients

47. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

49. Clinical validation of the quantitative Siemens SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers

50. Systemic inflammation as fuel for acute liver injury in COVID-19

Catalog

Books, media, physical & digital resources